RU97106720A - Способ лечения гемофтальма - Google Patents
Способ лечения гемофтальмаInfo
- Publication number
- RU97106720A RU97106720A RU97106720/14A RU97106720A RU97106720A RU 97106720 A RU97106720 A RU 97106720A RU 97106720/14 A RU97106720/14 A RU 97106720/14A RU 97106720 A RU97106720 A RU 97106720A RU 97106720 A RU97106720 A RU 97106720A
- Authority
- RU
- Russia
- Prior art keywords
- mosmol
- hemophthalmic
- molecular weight
- osmotic pressure
- hemodes
- Prior art date
Links
- 230000003204 osmotic Effects 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
Claims (1)
- Способ лечения гемофтальма внутривенным введением растворов низкомолекулярных соединений (хлористый натрий, глюкоза, маннитол) с осмотическим давлением выше 310 мОсмоль, отличающийся тем, что внутривенно вводят сбалансированный по основным электролитам с плазмой крови раствор поливинилпирролидона с молекулярной массой 12600 ± 2700 дальтон, имеющий осмотическое давление 5,0 ± 1,1 мОсмоль (гемодез) в количестве 200 мл в сутки не менее пяти дней.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU97106720A RU2148972C1 (ru) | 1997-04-22 | 1997-04-22 | Способ лечения гемофтальма |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU97106720A RU2148972C1 (ru) | 1997-04-22 | 1997-04-22 | Способ лечения гемофтальма |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU97106720A true RU97106720A (ru) | 1999-05-20 |
| RU2148972C1 RU2148972C1 (ru) | 2000-05-20 |
Family
ID=20192363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU97106720A RU2148972C1 (ru) | 1997-04-22 | 1997-04-22 | Способ лечения гемофтальма |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2148972C1 (ru) |
-
1997
- 1997-04-22 RU RU97106720A patent/RU2148972C1/ru active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4700482A1 (es) | Formulaciones de un analogo monomero de insulina | |
| MY101207A (en) | Treatment of diseases caused by retroviruses | |
| CA2201749A1 (en) | Stable aqueous alfa interferon solution formulations | |
| US5985310A (en) | Preservative systems for pharmaceutical compositions containing cyclodextrins | |
| CA2341568A1 (en) | Stabilized pharmaceutical composition in lyophilized form | |
| CA2336945A1 (en) | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate | |
| KR920011516A (ko) | 약제학적 조성물 | |
| RU97106720A (ru) | Способ лечения гемофтальма | |
| EP0213717A3 (en) | Iodophor containing suppository | |
| EP1283044A3 (en) | Injectable ready-to-use solutions containing an antitumor anthracycline glycoside | |
| WO2001009119A3 (en) | Chemokine receptor antagonists | |
| JPS57146723A (en) | Pharmaceutical preparation having improved absorption | |
| ATE332133T1 (de) | Pharmazeutische zusammensetzung enthaltend glyzin als stabilisator | |
| DE59510583D1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
| Moore et al. | Effect of beta-adrenergic blockade on plasma-renin activity and intractable hypertension in patients receiving regular dialysis treatment | |
| KIM et al. | High Dose of Amphotericin B in Intralipid Emulsion-based Delivery System in Immunocompromised Children with Invasive Fungal Infections | |
| MEP1108A (en) | Use of specific dose of fondaparinux sodium for the treatment of acs | |
| KR920003977A (ko) | 신장질환치료제 | |
| RU99113231A (ru) | Способ профилактики тромбогенных осложнений | |
| Breborowicz et al. | Local Anesthetic-Bupiv Acaine Increases the Peritoneal Transport of Solutes. Part I: In Vivo Study | |
| Battista et al. | Stability of ofloxacin in peritoneal dialysis solutions | |
| NO972303L (no) | Intravenöse lubeluzollösninger | |
| RU97109893A (ru) | Способ непрямой эндолимфатической антибиотикотерапии больных сепсисом | |
| UA32868A (uk) | Спосіб лікування резистивної форми епілепсії | |
| Lassen et al. | Treatment characteristics in patients surviving five to 18+ years. An analysis of 1714 consecutive patients |